NO2613784T3 - - Google Patents
Info
- Publication number
- NO2613784T3 NO2613784T3 NO11767034A NO11767034A NO2613784T3 NO 2613784 T3 NO2613784 T3 NO 2613784T3 NO 11767034 A NO11767034 A NO 11767034A NO 11767034 A NO11767034 A NO 11767034A NO 2613784 T3 NO2613784 T3 NO 2613784T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Medical Informatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38053910P | 2010-09-07 | 2010-09-07 | |
| PCT/GB2011/051658 WO2012032337A2 (fr) | 2010-09-07 | 2011-09-05 | Dispositif d'administration de médicament transdermique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2613784T3 true NO2613784T3 (fr) | 2018-05-12 |
Family
ID=44764181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO11767034A NO2613784T3 (fr) | 2010-09-07 | 2011-09-05 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10251834B2 (fr) |
| EP (1) | EP2613784B1 (fr) |
| JP (1) | JP5843864B2 (fr) |
| KR (2) | KR102084571B1 (fr) |
| AU (1) | AU2011300524B2 (fr) |
| CA (1) | CA2809927C (fr) |
| DK (1) | DK2613784T3 (fr) |
| ES (1) | ES2658913T3 (fr) |
| NO (1) | NO2613784T3 (fr) |
| NZ (1) | NZ608598A (fr) |
| PL (1) | PL2613784T3 (fr) |
| WO (1) | WO2012032337A2 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2673196T3 (es) * | 2009-05-08 | 2018-06-20 | Emplicure Ab | Composición para la administración sostenida de fármacos que comprende aglutinante geopolimérico |
| JP6513031B2 (ja) | 2013-02-01 | 2019-05-15 | ダブリュー・アール・グレース・アンド・カンパニー−コーンＷ Ｒ Ｇｒａｃｅ ＆ Ｃｏ−Ｃｏｎｎ | 液体テクノロジーのための担体としての多孔質シリカゲル |
| CA2962080A1 (fr) | 2014-09-24 | 2016-03-31 | Pain Therapeutics, Inc. | Co-cristal constitue de 4:3 naltrexone: 5-methyl-2-furaldehyde |
| CN106794155B (zh) * | 2014-10-14 | 2020-10-30 | 久光制药株式会社 | 贴附剂 |
| GB201503961D0 (en) * | 2015-03-09 | 2015-04-22 | Emplicure Ab | A transdermal drug administration device |
| JP7179245B2 (ja) | 2016-02-29 | 2022-11-29 | アンプリコン アクチエボラグ | ニコチンの蒸発及び吸入装置 |
| KR101719319B1 (ko) * | 2016-04-05 | 2017-03-23 | 주식회사 엘지생활건강 | 효율적인 피부 천공을 위한 마이크로니들 구조 |
| US9650338B1 (en) | 2016-07-29 | 2017-05-16 | VDM Biochemicals, Inc. | Opioid antagonist compounds and methods of making and using |
| CN106265584B (zh) * | 2016-08-31 | 2019-04-09 | 浙江工业大学 | 埃洛石纳米管为骨架的肠溶复合载药体系及其制备方法 |
| US10300454B2 (en) | 2017-04-18 | 2019-05-28 | Breakthrough Technologies, Llc. | Sulfur production |
| ES2908820T3 (es) * | 2017-12-14 | 2022-05-04 | Lts Lohmann Therapie Systeme Ag | Matriz de microagujas con un principio activo en forma de sales |
| CN110448543A (zh) * | 2019-09-16 | 2019-11-15 | 临沂大学 | 一种基于埃洛石纳米管/壳聚糖复合骨架的绿原酸肠溶缓释微球及其制备方法 |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0391893B1 (fr) | 1983-11-14 | 1993-08-25 | The University of Kentucky Research Foundation | Microspheres poreuses pour l'administration de medicaments, et procedes de production de ces microspheres poreuses |
| GB2196252B (en) | 1986-09-18 | 1990-10-17 | London Pharmacy Innovation | Gastric controlled-release dosage forms |
| IT1197316B (it) | 1986-10-01 | 1988-11-30 | Proter Spa | Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico |
| JP2702953B2 (ja) | 1988-01-30 | 1998-01-26 | オリンパス光学工業株式会社 | 薬液含浸セラミックス |
| IT1216570B (it) | 1988-04-08 | 1990-03-08 | Vectorpharma Int | Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione. |
| JPH02268104A (ja) | 1989-04-07 | 1990-11-01 | Kanebo Ltd | 抗菌性組成物 |
| US5443812A (en) | 1989-04-24 | 1995-08-22 | Kanebo Ltd. | Stabilized synthetic zeolite and a process for the preparation thereof |
| JPH07188000A (ja) | 1993-12-27 | 1995-07-25 | Bridgestone Corp | 薬用被覆材 |
| JPH0930988A (ja) | 1995-07-21 | 1997-02-04 | Sumitomo Osaka Cement Co Ltd | 薬剤徐放性多孔質セラミックス成形体及びその製造方法 |
| GB2307862A (en) * | 1995-12-05 | 1997-06-11 | David Jehan | Patch structures for transdermal therapy |
| WO1998023556A1 (fr) | 1996-11-25 | 1998-06-04 | Kabushiki Kaisya Advance | Procede de production de ceramiques |
| US5902591A (en) | 1997-04-03 | 1999-05-11 | La Prairie Sa | Stable topical cosmetic/pharmaceutical emulsion compositions containing ascorbic acid |
| US6503231B1 (en) | 1998-06-10 | 2003-01-07 | Georgia Tech Research Corporation | Microneedle device for transport of molecules across tissue |
| US6123925A (en) | 1998-07-27 | 2000-09-26 | Healthshield Technologies L.L.C. | Antibiotic toothpaste |
| US6342249B1 (en) | 1998-12-23 | 2002-01-29 | Alza Corporation | Controlled release liquid active agent formulation dosage forms |
| US6635281B2 (en) | 1998-12-23 | 2003-10-21 | Alza Corporation | Gastric retaining oral liquid dosage form |
| US20030118641A1 (en) | 2000-07-27 | 2003-06-26 | Roxane Laboratories, Inc. | Abuse-resistant sustained-release opioid formulation |
| AUPQ573300A0 (en) | 2000-02-21 | 2000-03-16 | Australian Nuclear Science & Technology Organisation | Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
| EP1272440A2 (fr) | 2000-03-24 | 2003-01-08 | Mark B. Lyles | Materiaux poreux de haute densite |
| CZ301790B6 (cs) | 2000-04-11 | 2010-06-23 | Sankyo Company Limited | Farmaceutický prípravek obsahující blokátor vápníku |
| US6602523B1 (en) | 2000-08-17 | 2003-08-05 | Technology Holding, Llc. | Composite material and process for increasing bioavailability and activity of a beneficial agent |
| US20020122828A1 (en) | 2001-03-02 | 2002-09-05 | Jun Liu | Hybrid porous materials for controlled release |
| CA2440069A1 (fr) | 2001-03-05 | 2002-09-12 | Ortho-Mcneil Pharmaceutical, Inc. | Compositions pharmaceutiques au gout dissimule |
| CA2458828A1 (fr) | 2001-09-24 | 2003-05-01 | James J. Barry | Dosage optimise pour extenseurs enduits d'un medicament |
| CA2461708C (fr) | 2001-09-28 | 2012-08-07 | Nutraceutix, Inc. | Systeme de distribution de composant biologique |
| AU2002350207A1 (en) * | 2001-11-19 | 2003-06-10 | Control Delivery Systems, Inc. | Topical delivery of codrugs |
| WO2003090729A1 (fr) | 2002-04-23 | 2003-11-06 | Alza Corporation | Systemes analgesiques transdermiques avec risques d'abus reduits |
| WO2003092785A1 (fr) | 2002-04-30 | 2003-11-13 | Morteza Shirkhanzadeh | Reseaux de micro-aiguilles comportant un revetement de phosphate de calcium poreux et des agents bioactifs |
| US8062573B2 (en) * | 2002-09-16 | 2011-11-22 | Theraject, Inc. | Solid micro-perforators and methods of use |
| SE524334C2 (sv) | 2002-09-30 | 2004-07-27 | Cerbio Tech Ab | Värmegenererande biokompatibla keramiska material och förfarande för dess framställning |
| SE525236C2 (sv) | 2002-10-31 | 2005-01-11 | Cerbio Tech Ab | Förfarande för framställning av strukturerade keramiska beläggningar och belagda anordningar framställda med detta förfarande |
| SE524494C2 (sv) | 2002-12-31 | 2004-08-17 | Doxa Ab | Kemiskt bundna biomaterialelement med skräddarsydda egenskaper |
| US20070258926A1 (en) | 2003-10-15 | 2007-11-08 | Ltt Bio-Pharma Co., Ltd. | Composition containing retinoic acid nanoparticles coated with inorganic salt of polyvalent metal |
| BRPI0416068A (pt) | 2003-10-29 | 2007-01-02 | Doxa Ab | sistema de duas etapas para melhorar as caracterìsticas inicial e final de um biomaterial |
| US20050181049A1 (en) | 2003-11-19 | 2005-08-18 | Dong Liang C. | Composition and method for enhancing bioavailability |
| WO2005065319A2 (fr) | 2003-12-31 | 2005-07-21 | Cima Labs Inc. | Forme galenique de fentanyl generalement lineaire effervescente et orale et ses procedes d'administration |
| US7914813B2 (en) | 2004-02-03 | 2011-03-29 | Hisamitsu Pharmaceutical Co., Inc. | Interface for transdermal drug administration device |
| US7315758B2 (en) * | 2004-06-03 | 2008-01-01 | Lynntech, Inc. | Transdermal delivery of therapeutic agent |
| EA013632B1 (ru) | 2004-06-28 | 2010-06-30 | Лайфсайкл Фарма А/С | Пористые таблетки в качестве носителей для жидких композиций |
| KR20070042177A (ko) | 2004-07-13 | 2007-04-20 | 알타이어나노 인코포레이티드 | 약물의 조절 방출을 위한 세라믹 구조체 |
| JP2008506699A (ja) | 2004-07-13 | 2008-03-06 | アルテアーナノ，インコーポレーテッド | 薬物転用防止用セラミック構造体 |
| WO2006015299A2 (fr) * | 2004-07-30 | 2006-02-09 | Microchips, Inc. | Dispositif multi-reservoir pour la delivrance de medicament transdermique et la detection |
| KR20070043894A (ko) | 2004-08-19 | 2007-04-25 | 알자 코포레이션 | 제어 방출형 나노입자 활성제 제제 제형 및 방법 |
| US8535702B2 (en) | 2005-02-01 | 2013-09-17 | Boston Scientific Scimed, Inc. | Medical devices having porous polymeric regions for controlled drug delivery and regulated biocompatibility |
| FR2881652B1 (fr) | 2005-02-08 | 2007-05-25 | Flamel Technologies Sa | Forme pharmaceutique orale microparticulaire anti-mesuage |
| WO2006096544A1 (fr) | 2005-03-04 | 2006-09-14 | Altairnano, Inc. | Structures ceramiques pour liberation controlee de substances actives sur le plan biologique |
| DE102005040429A1 (de) | 2005-08-25 | 2007-03-01 | Heraeus Kulzer Gmbh | Wirkstofffreisetzungssystem und seine Verwendung |
| US8652529B2 (en) | 2005-11-10 | 2014-02-18 | Flamel Technologies | Anti-misuse microparticulate oral pharmaceutical form |
| US7682445B2 (en) | 2005-12-08 | 2010-03-23 | Doxa Ab | Powdered CBC system with improved reaction feature |
| EP1971351A2 (fr) | 2005-12-29 | 2008-09-24 | Robert Basic | Composition minérale-herbale comprenant de la zéolite et un extrait de racine d'astragalus membranaceus pour le traitement des allergies |
| US20080200262A1 (en) | 2006-01-20 | 2008-08-21 | David Whitby | Video game instruction card holder |
| US20070212414A1 (en) | 2006-03-08 | 2007-09-13 | Penwest Pharmaceuticals Co. | Ethanol-resistant sustained release formulations |
| US20070248656A1 (en) | 2006-04-25 | 2007-10-25 | Galer Bradley S | Topical preparation dispensers and methods of using the same |
| US9023400B2 (en) | 2006-05-24 | 2015-05-05 | Flamel Technologies | Prolonged-release multimicroparticulate oral pharmaceutical form |
| DE102006028781A1 (de) | 2006-06-23 | 2007-12-27 | Robert Bosch Gmbh | Verfahren zur Herstellung von porösen Mikronadeln und ihre Verwendung |
| US20080214987A1 (en) * | 2006-12-22 | 2008-09-04 | Nanomed Devices, Inc. | Microdevice And Method For Transdermal Delivery And Sampling Of Active Substances |
| WO2008105738A1 (fr) | 2007-03-01 | 2008-09-04 | Doxa Ab | Composition de ciment injectable à usage orthopédique et dentaire |
| WO2008105737A1 (fr) | 2007-03-01 | 2008-09-04 | Doxa Ab | Composition de ciment stable à usage orthopédique et dentaire |
| WO2008105739A1 (fr) | 2007-03-01 | 2008-09-04 | Doxa Ab | Support d'implant de médicaments pour distribution de médicaments |
| EP2139531A4 (fr) | 2007-03-28 | 2013-01-09 | Doxa Ab | Support pour l'administration de médicaments |
| CN101104080B (zh) | 2007-04-24 | 2011-06-22 | 深圳市鸿华投资有限公司 | 沸石止血敷料及其制备方法和用途 |
| GB0709541D0 (en) | 2007-05-17 | 2007-06-27 | Jagotec Ag | Pharmaceutical excipient |
| EP2100850A1 (fr) | 2008-03-11 | 2009-09-16 | Stichting Voor De Technische Wetenschappen | Ensemble de micro-aiguille et procédé de fabrication de micro-aiguilles |
| EP2398577A2 (fr) | 2009-02-19 | 2011-12-28 | Bonner, Alex Garfield | Réseau polymère imbriqué poreux |
-
2011
- 2011-09-05 NO NO11767034A patent/NO2613784T3/no unknown
- 2011-09-05 JP JP2013527682A patent/JP5843864B2/ja active Active
- 2011-09-05 WO PCT/GB2011/051658 patent/WO2012032337A2/fr active Application Filing
- 2011-09-05 EP EP11767034.9A patent/EP2613784B1/fr active Active
- 2011-09-05 KR KR1020187003892A patent/KR102084571B1/ko active IP Right Grant
- 2011-09-05 DK DK11767034.9T patent/DK2613784T3/da active
- 2011-09-05 PL PL11767034T patent/PL2613784T3/pl unknown
- 2011-09-05 KR KR1020137008926A patent/KR20140003405A/ko active Application Filing
- 2011-09-05 US US13/821,039 patent/US10251834B2/en active Active
- 2011-09-05 NZ NZ60859811A patent/NZ608598A/en not_active IP Right Cessation
- 2011-09-05 ES ES11767034.9T patent/ES2658913T3/es active Active
- 2011-09-05 AU AU2011300524A patent/AU2011300524B2/en not_active Ceased
- 2011-09-05 CA CA2809927A patent/CA2809927C/fr active Active
-
2019
- 2019-04-05 US US16/376,317 patent/US10736838B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012032337A2 (fr) | 2012-03-15 |
| PL2613784T3 (pl) | 2018-05-30 |
| NZ608598A (en) | 2015-03-27 |
| KR102084571B1 (ko) | 2020-03-04 |
| CA2809927A1 (fr) | 2012-03-15 |
| ES2658913T3 (es) | 2018-03-12 |
| US10251834B2 (en) | 2019-04-09 |
| US20190282494A1 (en) | 2019-09-19 |
| EP2613784B1 (fr) | 2017-12-13 |
| AU2011300524B2 (en) | 2014-10-23 |
| KR20140003405A (ko) | 2014-01-09 |
| US10736838B2 (en) | 2020-08-11 |
| JP5843864B2 (ja) | 2016-01-13 |
| EP2613784A2 (fr) | 2013-07-17 |
| KR20180018840A (ko) | 2018-02-21 |
| CA2809927C (fr) | 2019-08-20 |
| WO2012032337A3 (fr) | 2012-04-26 |
| AU2011300524A1 (en) | 2013-02-21 |
| US20130273119A1 (en) | 2013-10-17 |
| DK2613784T3 (da) | 2018-01-29 |
| JP2013536875A (ja) | 2013-09-26 |